For the year ending 2025-12-31, ATRA made $120,772K in revenue. $32,681K in net income. Net profit margin of 27.06%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 120,772 | 128,940 | ||
| Cost of commercialization revenue | 21,212 | 21,009 | ||
| Research and development expenses | 37,445 | 151,483 | ||
| General and administrative expenses | 26,253 | 39,886 | ||
| Total costs and operating expenses | 84,910 | 212,378 | ||
| Loss from operations | 35,862 | -83,438 | ||
| Interest income | 683 | 2,110 | ||
| Interest expense | 3,792 | 4,615 | ||
| Other income (expense), net | -34 | 528 | ||
| Total other income (expense), net | -3,143 | -1,977 | ||
| Loss before provision for (benefit from) income taxes | 32,719 | -85,415 | ||
| Provision for (benefit from) income taxes | 31 | -12 | ||
| Net loss | 32,688 | -85,403 | ||
| Unrealized gain (loss) on available-for-sale securities | -7 | 212 | ||
| Comprehensive loss | 32,681 | -85,191 | ||
| Basic EPS | 2.61 | -11.41 | ||
| Diluted EPS | 2.57 | -11.41 | ||
| Basic Average Shares | 12,544,000 | 7,488,000 | ||
| Diluted Average Shares | 12,718,000 | 7,488,000 | ||
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA)